Evogene | EVGN - Sales Revenues

Stock Price
248.00
Daily Change
3.20 1.31%
Monthly
-0.76%
Yearly
-38.19%
Q2 Forecast
237.60

Evogene reported $314K in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
CVR Partners USD 163.55M 5.01M Sep/2025
Evogene USD 314K 2K Dec/2025
FutureFuel USD 19.84M 31.3M Dec/2025
Globe Specialty Metals USD 311.7M 75.16M Sep/2025
Hawkins USD 244.1M 36.33M Dec/2025
Innospec USD 455.6M 13.7M Dec/2025
Intrepid Potash USD -1.84M 703K Sep/2024
Koppers USD 432.7M 52.6M Dec/2025
Kronos Worldwide USD 418.3M 38.6M Dec/2025
LSB Industries USD 165.05M 9.62M Dec/2025
Materion USD 489.7M 44.9M Dec/2025
Minerals Technologies USD 520M 12.4M Dec/2025
Oil Dri Of America USD 113.7M 8.03M Jul/2024
Rayonier Advanced Materials USD 417.54M 64.71M Dec/2025
Sensient Technologies USD 435.8M 42.4M Mar/2026
Stepan USD 553.89M 36.39M Dec/2025
Tronox USD 730M 31M Dec/2025
Valhi USD 494.5M 9M Dec/2025
WD-40 USD 161.67M 7.25M Dec/2025